Logo image of OFAL

OFA GROUP (OFAL) Stock Fundamental Analysis

USA - NASDAQ:OFAL - KYG6713S1066 - Common Stock

1.33 USD
-0.01 (-0.75%)
Last: 9/24/2025, 7:36:09 PM
2.2 USD
+0.87 (+65.41%)
After Hours: 9/24/2025, 7:36:09 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to OFAL. OFAL was compared to 81 industry peers in the Professional Services industry. While OFAL seems to be doing ok healthwise, there are quite some concerns on its profitability. OFAL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year OFAL has reported negative net income.
In the past year OFAL has reported a negative cash flow from operations.
OFAL Yearly Net Income VS EBIT VS OCF VS FCFOFAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -200K -400K -600K

1.2 Ratios

Looking at the Return On Assets, with a value of -194.26%, OFAL is doing worse than 93.83% of the companies in the same industry.
Industry RankSector Rank
ROA -194.26%
ROE N/A
ROIC N/A
ROA(3y)-41.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OFAL Yearly ROA, ROE, ROICOFAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 100 -100 200 -200 -300

1.3 Margins

OFAL has a Gross Margin (43.86%) which is in line with its industry peers.
OFAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OFAL Yearly Profit, Operating, Gross MarginsOFAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, OFAL has about the same amount of shares outstanding.
The debt/assets ratio for OFAL has been reduced compared to a year ago.
OFAL Yearly Shares OutstandingOFAL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 2M 4M 6M 8M 10M
OFAL Yearly Total Debt VS Total AssetsOFAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 100K 200K 300K 400K

2.2 Solvency

An Altman-Z score of 6.91 indicates that OFAL is not in any danger for bankruptcy at the moment.
The Altman-Z score of OFAL (6.91) is better than 90.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 6.91
ROIC/WACCN/A
WACCN/A
OFAL Yearly LT Debt VS Equity VS FCFOFAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 200K -200K 400K

2.3 Liquidity

OFAL has a Current Ratio of 1.42. This is a normal value and indicates that OFAL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OFAL (1.42) is comparable to the rest of the industry.
OFAL has a Quick Ratio of 1.42. This is a normal value and indicates that OFAL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.42, OFAL is in line with its industry, outperforming 53.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
OFAL Yearly Current Assets VS Current LiabilitesOFAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 100K 200K 300K

0

3. Growth

3.1 Past

The earnings per share for OFAL have decreased strongly by -1074.29% in the last year.
OFAL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -61.93%.
EPS 1Y (TTM)-1074.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1074.29%
Revenue 1Y (TTM)-61.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OFAL Yearly Revenue VS EstimatesOFAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 200K 400K 600K 800K 1M

0

4. Valuation

4.1 Price/Earnings Ratio

OFAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OFAL Price Earnings VS Forward Price EarningsOFAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFAL Per share dataOFAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OFAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OFA GROUP

NASDAQ:OFAL (9/24/2025, 7:36:09 PM)

After market: 2.2 +0.87 (+65.41%)

1.33

-0.01 (-0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.51M
AnalystsN/A
Price TargetN/A
Short Float %8.55%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 91.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.01
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -194.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.86%
FCFM N/A
ROA(3y)-41.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 6.91
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1074.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1074.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-61.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-687.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.15%
OCF growth 3YN/A
OCF growth 5YN/A